Delivery Order SPE2DB20D1109-SPE2DB25FP48L
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,027.70 for Ingrezza 80 mg capsules (30-count units) on July 21, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Ingrezza is a prescription medication used to treat tardive dyskinesia, a movement disorder, and represents...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Ingrezza 40 mg capsules (30-count units) valued at $3,676.12. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 18, 2025, with fulfillment occurring at the contractor's facility in Conshohocken, Pennsylvania. Ingrezza is a prescription medication used primarily for the treatment of tardive dyskinesia, a neurological movement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ingrezza 40 mg capsules (30-count units) under a firm fixed-price contract with a ceiling value of $3,676.12. The delivery order, issued on July 18, 2025, with an ultimate completion date of August 8, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ingrezza 80 mg capsules (30-count units) under a firm fixed price contract valued at $4,027.70, with an ultimate completion date of August 15, 2025. This non-competitive delivery order was issued on July 25, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The award represents a child order under the company's larger...
- The Defense Logistics Agency awarded a $3,676.12 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Ingrezza 40 mg capsules (30-count units). The contract, which is not set-aside, carries a firm fixed price structure with an ultimate completion date of August 21, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. This award represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for the supply of INGREZZA 80 mg capsules (30-count) on July 22, 2025, with an ultimate completion date of August 12, 2025. This firm fixed price delivery order represents a non-competitive set-aside and will be performed at the contractor's location in Conshohocken, Pennsylvania. INGREZZA is a neurological medication used to treat tardive dyskinesia, a movement disorder associated with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,083.10 to AmerisourceBergen Drug Corp for the supply of Ingrezza 80 mg capsules (30-count units) under a firm fixed-price contract. The award was issued on July 29, 2025, with an ultimate completion date of August 19, 2025. This non-competitive delivery order does not utilize a set-aside designation and represents a routine pharmaceutical procurement fulfilling federal medical supply requirements. Performance will be...
- The Defense Logistics Agency awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for the supply of Ingrezza 80 mg capsules (30-count units) under a firm fixed-price contract. The award was made on July 30, 2025, with an ultimate completion date of August 20, 2025, with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the delivery from its corporate office location. This delivery order represents a specific...
- The Defense Logistics Agency awarded a $9,358.65 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 40mg capsules of Ingrezza to treat tardive dyskinesia. As the prime contractor, Amerisourcebergen will deliver 30 capsules to a location in Conshohocken, Pennsylvania under a contract running from August 18 to September 11, 2023. No subcontractors or set aside designations were specified. This order is likely in support of the Defense Health Agency's mission to provide...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ingrezza 60 mg capsules (30-count units) with a ceiling value of $4,049.61. This firm fixed-price, competitively awarded delivery order is scheduled for completion by August 12, 2025, with performance taking place at the contractor's Conshohocken, Pennsylvania location. The contract represents a non-set-aside procurement executed under DLA's broader pharmaceutical supply framework for...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP48LDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ingrezza 80 mg capsules (30-count units) under a firm fixed price contract valued at $4,027.70. The delivery order, issued on July 29, 2025, with an ultimate completion date of August 19, 2025, represents a competitively awarded non-set-aside procurement. Ingrezza (valbenazine) is an FDA-approved medication used to treat tardive dyskinesia, a neurological condition characterized by involuntary movements. The product will be performed and distributed from AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and a major hub for pharmaceutical distribution operations supporting federal medical supply chains. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), a $999.9 billion comprehensive global pharmaceutical support vehicle valued through December 2026. As the prime contractor under this vehicle, AmerisourceBergen serves as a critical pharmaceutical distributor for military healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other federal healthcare entities. The company's established role as a major pharmaceutical vendor demonstrates its capability to fulfill specialized medical procurement needs through competitively awarded delivery orders, supporting the broader federal medical supply chain infrastructure across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 7/29/25 |